Evidence map›Paper›PMID 38036693›Full record

ReviewInternational orthopaedics2024

Total hip replacement among sickle cell patients in a low-income country-Yemen.

Anwar Abdulqader Mughalles, Ghamdan Gamal Alkholidy, Mohammed Saleh AlSaifi, Wael Mohamed Al-Gabaly, Kawkab Mohammed Al-Haddad

Abstract readReview
PubMed Publisher
In one paragraph

Review in International orthopaedics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Anwar Abdulqader MughallesFaculty of Medicine and Health Sciences, Sana'a University, Sana'a, Yemen.
Ghamdan Gamal AlkholidyAl-Thawra Modern General Hospital, Sana'a, Yemen. ghamdangamal@gmail.com.ORCID 0000-0003-0991-0185
Mohammed Saleh AlSaifiAl-Thawra Modern General Hospital, Sana'a, Yemen.
Wael Mohamed Al-GabalyAl-Thawra Modern General Hospital, Sana'a, Yemen.
Kawkab Mohammed Al-HaddadFaculty of Medicine and Health Sciences, Sana'a University, Sana'a, Yemen.
Sana'a University · YEUniversity of Modern Sciences · YE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSickle cell patients presented with progressive hip pain and limitation of daily activities, as evidenced by low preoperative hip scores and failed conservative therapy. Management of femoral head avascular necrosis (AVN) using total hip replacement (THR) in sickle cell disease (SCD) is widespread in developed countries, but it is still in its initiation stage in developing countries. The outcome of using cementless THR among SCD patients is still unknown with lack of published studies from regional countries. This study aimed to evaluate the outcome of using cementless primary THR among patients with sickle cell disease with end-stage hip avascular necrosis in Yemen.

methodsThirty cementless primary total hip arthroplasty (THA) were performed for AVN of the femoral head in 27 sickle cell patients, at Al.-Thawra Modern General Hospital-Sana'a, Yemen, from January 2018 to December 2022.

resultsThe mean age of the patients was 27 ± five years (ranged 18-37 years) with a male to female ratio was 3:1. Steinberg staging for hip AVN was stage IV, one patient (3%); stage VI, thirteen patients (45%); and stage V, sixteen patients (51%). THR was on right side 14 (52%), left side 10 (37%), and bilateral 3 (11%). The implant used was ceramic on polyethylene acetabular liner. All patients showed improvement in Harris hip score from preoperative mean hip score was 25 ± 8 points to postoperative mean hip score was 88 ± 6 points at the last follow-up. Mean of the length of stay in hospital was 12.7 ± eight days (ranged from 4 to 32 days); the mean operating time was 107 ± 23 min. Three cases had superficial wound infection; four patients had five intraoperative fractures; two cases had pulmonary complications; one case had abdominal crisis. All patients had postoperative leg length discrepancy less than 2 cm. None had deep infection, nerve injury, wound hematoma, aseptic loosing, dislocation, DVT, heterotopic ossification, or death.

conclusionTHR in SCD has a good outcome using cementless THA with a low rate of complication in Yemen, a developing country.

Indexed as

Anemia, Sickle CellArthroplasty, Replacement, HipFemur Head NecrosisHip ProsthesisAdolescentAdultFemaleFollow-Up StudiesHumansMaleRetrospective StudiesTreatment OutcomeYemenYoung AdultCementless THASickle cell disease; Femoral head AVNTotal hip arthroplasty

Identifiers

PMID38036693
OpenAlexW4389209923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.